Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity.
具有糖皮质激素受体结合活性的新型1,2,3,4-四氢喹喔啉衍生物。
Receptor binding activity of the two mutants gives 66% and 54% of that of human proinsulin, respectively, while radio immuno activity drops to 22% and 9%.
两者的胰岛素受体活性分别为人胰岛素原的66%及54%,而胰岛素的放射免疫活性分别降为人胰岛素原的22%及9%。
The binding of PTH with its receptor on ROS cell will stimulate adenylate cyclase activity (ac).
当该细胞质膜上的PTH受体与PTH结合后,可激发腺苷酸环化酶(AC)的活性。
应用推荐